Rob Davis
Rob Davis is the CEO of Merck & Co., having taken over the operational leadership in 2021 after serving as CFO. Under his guidance, the company has faced challenges related to the performance of its blockbuster drug Keytruda and the HPV vaccine Gardasil, navigating through market uncertainties and striving to maintain investor confidence.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Turkey | 1 | 9.00 | 0.09% | +0% | 84,339,067 | 76,118 | $720,000 | 650$ |
| Totals | 1 | 84,339,067 | 76,118 | $720,000 | 650$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Turkey:
Rob Davis is the lead author from the British Museum who discussed the significance of fire control in human history.
9
Bahamas:
Rob Davis, along with his wife Youlette, is involved in the Coconut Factory, advocating for local entrepreneurship in the coconut industry.
6
United States:
Merck, under Rob Davis, will spend $9 billion to grow its domestic vaccine and drug production capacity.
8
Switzerland:
CEO Rob Davis, who has led the operational business since summer 2021, reported a significant slowdown in revenue growth for Gardasil.
5